|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-3-30
|
|
pubmed:abstractText |
Macrophage inhibitory cytokine-1 (MIC-1) belongs to the bone morphogenic protein/transforming growth factor-beta (BMP/TGF-beta) superfamily. Serum MIC-1 concentrations are elevated in patients with advanced prostate cancer. The effects of MIC-1 on prostate cancer bone metastases are unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1097-0045
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2009 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
652-61
|
|
pubmed:meshHeading |
pubmed-meshheading:19152406-Animals,
pubmed-meshheading:19152406-Bone Neoplasms,
pubmed-meshheading:19152406-Cell Line,
pubmed-meshheading:19152406-Cell Line, Tumor,
pubmed-meshheading:19152406-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19152406-Growth Differentiation Factor 15,
pubmed-meshheading:19152406-Humans,
pubmed-meshheading:19152406-Male,
pubmed-meshheading:19152406-Mice,
pubmed-meshheading:19152406-Mice, Knockout,
pubmed-meshheading:19152406-Neoplasm Metastasis,
pubmed-meshheading:19152406-Osteoblasts,
pubmed-meshheading:19152406-Osteoclasts,
pubmed-meshheading:19152406-Prostatic Neoplasms,
pubmed-meshheading:19152406-Toll-Like Receptor 9,
pubmed-meshheading:19152406-Weight Loss
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
|
|
pubmed:affiliation |
Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-3300, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
